Related Experiment Video

Updated: Jun 27, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis

Peter Libby1

  • 1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. plibby@rics.bwh.harvard.edu

Journal of Lipid Research
|December 20, 2008
PubMed

Insights

Atherosclerosis complications are not solely due to arterial narrowing. Plaque disruption, not just stenosis, is key to understanding thrombotic events in atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Clinical Cardiology

Background:

  • Traditionally, atherosclerosis complications were linked to critical arterial stenosis impeding blood flow.
  • Contemporary understanding shifts focus to thrombotic events, challenging the stenosis-only paradigm.

Purpose of the Study:

  • To explore the transformation in understanding thrombotic complications of atherosclerosis.
  • To reconcile clinical observations with pathological findings regarding plaque disruption.

Main Methods:

  • Review of clinical observations and pathological findings.
  • Analysis of angiographic studies and culprit lesions in acute myocardial infarction.
  • Integration of data from pathology and clinical cardiology.

Main Results:

  • Acute myocardial infarction can be caused by plaques without high-grade stenosis.
  • Plaque disruption, rather than critical narrowing, is often implicated in fatal coronary thrombi.
  • A convergence of clinical and pathological data highlights plaque disruption mechanisms.

Conclusions:

  • The understanding of atherosclerosis complications has evolved beyond simple arterial stenosis.
  • Plaque disruption is a critical factor in precipitating thromboses.
  • Further research into plaque disruption mechanisms is essential for managing atherosclerosis complications.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...